Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Buckwalter Place Blvd #130
Bluffton, SC 29910Phone+1 843-836-7101Fax+1 843-836-7112
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 1993
Medical College of GeorgiaInternship, Internal Medicine, 1990 - 1991- Medical College of GeorgiaResidency, Internal Medicine, 1987 - 1990
Medical University of South CarolinaClass of 1987
Certifications & Licensure
GA State Medical License 1990 - 2025
SC State Medical License 1988 - 2025
NC State Medical License 1991 - 2011- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
- GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC Start of enrollment: 2019 Jan 03
- realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL Start of enrollment: 2021 Sep 20
Roles: Contact
Publications & Presentations
PubMed
- 12 citationsA Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia...Pere Gascón, Rajnish Nagarkar, Martin Šmakal, Konstantinos N. Syrigos, Carlos H. Barrios
Journal of Thoracic Oncology. 2020-02-01 - 12 citationsA Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.Ramesh K. Ramanathan, Gary W. Thomas, Alok A. Khorana, Satish Shah, Cathy Zhou
Oncology. 2019-01-01 - 376 citationsNeratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...Miguel Martin, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy
The Lancet. Oncology. 2017-12-01
Press Mentions
Trump Breaks the Quarantine, Works in His Office and Says That Getting Infected Was a Blessing from GodOctober 8th, 2020
Hilton Head Hires: OCTOBER 2019September 27th, 2019
Hilton Head Cancer Patients Get a Special Delivery of Warmth and HopeJuly 6th, 2017
Professional Memberships
- South Carolina Oncology SocietyExecutive Board Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
